Class information for:
Level 1: STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
413 3505 34.5 75%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
171 3       MONASCUS//CITRININ//MONASCUS PURPUREUS 58457
419 2             STATINS//EZETIMIBE//SIMVASTATIN 16502
413 1                   STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN 3505

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 STATINS authKW 318274 15% 7% 518
2 LOW DENSITY LIPOPROTEIN CHOLESTEROL authKW 131976 3% 14% 109
3 ATORVASTATIN authKW 112556 4% 8% 153
4 LIPID LOWERING authKW 107821 1% 26% 48
5 ROSUVASTATIN authKW 101007 3% 13% 89
6 HYPERCHOLESTEROLEMIA authKW 92517 6% 5% 198
7 LIPID LOWERING DRUGS authKW 85598 1% 23% 43
8 CORONARY HEART DISEASE authKW 85001 7% 4% 257
9 LIPID LOWERING THERAPY authKW 82193 1% 23% 41
10 LDL C authKW 68646 1% 16% 48

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Cardiac & Cardiovascular System 32096 38% 0% 1325
2 Medicine, General & Internal 15574 31% 0% 1095
3 Peripheral Vascular Diseases 3865 10% 0% 363
4 Health Care Sciences & Services 2227 6% 0% 203
5 Pharmacology & Pharmacy 1762 15% 0% 536
6 Health Policy & Services 1453 4% 0% 126
7 Primary Health Care 1059 2% 0% 64
8 Endocrinology & Metabolism 428 6% 0% 193
9 Geriatrics & Gerontology 398 2% 0% 73
10 Medicine, Research & Experimental 148 4% 0% 128

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANAL COST EFFECT CARE 64525 0% 44% 17
2 SECT ATHEROSCLEROSIS LIPID 36290 0% 83% 5
3 CHOLESTEROL EDUC PROGRAM 34840 0% 100% 4
4 US MED SCI AFFAIRS 28445 0% 47% 7
5 INDEPENDENT LIPIDOL 26130 0% 100% 3
6 HEART DIS PREVENT CLIN 25328 0% 36% 8
7 CARDIAC REHABIL CHOLESTEROL CLIN 19596 0% 75% 3
8 POST CABG COORDINATING 19596 0% 75% 3
9 DIENST ENDOCRINOL METAB VOEDING 17420 0% 100% 2
10 EFFECTIVENESS EVALUAT UNIT 17420 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMERICAN JOURNAL OF CARDIOLOGY 31488 9% 1% 311
2 ATHEROSCLEROSIS SUPPLEMENTS 18068 1% 9% 24
3 JOURNAL OF CARDIOVASCULAR RISK 15966 1% 9% 21
4 AMERICAN JOURNAL OF MANAGED CARE 15584 2% 3% 70
5 EUROPEAN HEART JOURNAL SUPPLEMENTS 14895 1% 4% 42
6 CARDIOVASCULAR THERAPY AND PREVENTION 12669 1% 4% 33
7 CURRENT OPINION IN LIPIDOLOGY 12081 1% 3% 43
8 CURRENT MEDICAL RESEARCH AND OPINION 10890 2% 2% 75
9 CLINICAL THERAPEUTICS 8024 2% 1% 68
10 INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 7975 2% 1% 62

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 STATINS 318274 15% 7% 518 Search STATINS Search STATINS
2 LOW DENSITY LIPOPROTEIN CHOLESTEROL 131976 3% 14% 109 Search LOW+DENSITY+LIPOPROTEIN+CHOLESTEROL Search LOW+DENSITY+LIPOPROTEIN+CHOLESTEROL
3 ATORVASTATIN 112556 4% 8% 153 Search ATORVASTATIN Search ATORVASTATIN
4 LIPID LOWERING 107821 1% 26% 48 Search LIPID+LOWERING Search LIPID+LOWERING
5 ROSUVASTATIN 101007 3% 13% 89 Search ROSUVASTATIN Search ROSUVASTATIN
6 HYPERCHOLESTEROLEMIA 92517 6% 5% 198 Search HYPERCHOLESTEROLEMIA Search HYPERCHOLESTEROLEMIA
7 LIPID LOWERING DRUGS 85598 1% 23% 43 Search LIPID+LOWERING+DRUGS Search LIPID+LOWERING+DRUGS
8 CORONARY HEART DISEASE 85001 7% 4% 257 Search CORONARY+HEART+DISEASE Search CORONARY+HEART+DISEASE
9 LIPID LOWERING THERAPY 82193 1% 23% 41 Search LIPID+LOWERING+THERAPY Search LIPID+LOWERING+THERAPY
10 LDL C 68646 1% 16% 48 Search LDL+C Search LDL+C

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 BAIGENT, C , KEECH, A , KEARNEY, PM , BLACKWELL, L , BUCK, G , POLLICINO, C , KIRBY, A , SOURJINA, T , PETO, R , COLLINS, R , ET AL (2005) EFFICACY AND SAFETY OF CHOLESTEROL-LOWERING TREATMENT: PROSPECTIVE META-ANALYSIS OF DATA FROM 90,056 PARTICIPANTS IN 14 RANDOMISED TRIALS OF STATINS.LANCET. VOL. 366. ISSUE 9493. P. 1267-1278 27 71% 3243
2 WENG, TC , YANG, YHK , LIN, SJ , TAI, SH , (2010) A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE THERAPEUTIC EQUIVALENCE OF STATINS.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 35. ISSUE 2. P. 139 -151 57 78% 113
3 GRUNDY, SM , CLEEMAN, JI , MERZ, CNB , BREWER, HB , CLARK, LT , HUNNINGHAKE, DB , PASTERNAK, RC , SMITH, SC , STONE, NJ , (2004) IMPLICATIONS OF RECENT CLINICAL TRIALS FOR THE NATIONAL CHOLESTEROL EDUCATION PROGRAM ADULT TREATMENT PANEL III GUIDELINES.CIRCULATION. VOL. 110. ISSUE 2. P. 227-239 27 66% 3252
4 WARD, S , JONES, ML , PANDOR, A , HOLMES, M , ARA, R , RYAN, A , YEO, W , PAYNE, N , (2007) A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION OF STATINS FOR THE PREVENTION OF CORONARY EVENTS.HEALTH TECHNOLOGY ASSESSMENT. VOL. 11. ISSUE 14. P. 1 -+ 112 41% 89
5 ADAMS, SP , TSANG, M , WRIGHT, JM , (2012) LIPID LOWERING EFFICACY OF ATORVASTATIN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - 193 22% 1
6 GUMBS, PD , VERSCHUREN, MWM , MANTEL-TEEUWISSE, AK , DE WIT, AG , DE BOER, A , KLUNGEL, OH , (2007) ECONOMIC EVALUATIONS OF CHOLESTEROL-LOWERING DRUGS - A CRITICAL AND SYSTEMATIC REVIEW.PHARMACOECONOMICS. VOL. 25. ISSUE 3. P. 187-199 59 74% 4
7 CHEN, CY , CHUANG, SY , FANG, CC , HUANG, LC , HSIEH, IC , PAN, WH , YEH, HI , WU, CC , YIN, WH , CHEN, JW , (2014) GENDER DISPARITIES IN OPTIMAL LIPID CONTROL AMONG PATIENTS WITH CORONARY ARTERY DISEASE.JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. VOL. 21. ISSUE . P. S20 -S28 45 75% 4
8 MCTAGGART, F , JONES, P , (2008) EFFECTS OF STATINS ON HIGH-DENSITY LIPOPROTEINS: A POTENTIAL CONTRIBUTION TO CARDIOVASCULAR BENEFIT.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 22. ISSUE 4. P. 321 -338 74 49% 46
9 TAYLOR, F , HUFFMAN, MD , MACEDO, AF , MOORE, THM , BURKE, M , SMITH, GD , WARD, K , EBRAHIM, S , (2013) STATINS FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - 69 36% 72
10 DURRINGTON, P , (2002) THE HUMAN AND ECONOMIC COSTS OF UNDERTREATMENT WITH STATINS.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. VOL. 56. ISSUE 5. P. 357 -368 54 82% 15

Classes with closest relation at Level 1


Rank Class id link
1 37173 BLOOD ELEMENTAL LEVELS//CHOLESTEROL RATIOS//LIPOPROTEIN CHOLESTEROL RATIO
2 18626 PITAVASTATIN//NK 104//CAS 147526 32 7
3 13608 EZETIMIBE//NPC1L1//CHOLESTEROL ABSORPTION INHIBITOR
4 7604 CORONARY HEART DISEASE RISK FUNCTIONS//FRAMINGHAM//REGICOR
5 9257 PRAVASTATIN//HMG COA REDUCTASE INHIBITORS//MEVALONIC ACID
6 15692 STATINS//GRP COGNIT DECLINE DEGENERAT VASC DISORDERS//GRP PHARMACOL CEREBRAL I EMIA
7 2292 STATINS//ATORVASTATIN//HMG COA REDUCTASE INHIBITORS
8 7494 STATINS//RHABDOMYOLYSIS//STATIN INTOLERANCE
9 28664 POLYPILL//BLOOD PRESSURE LOWERING AGENTS//POLYCAP
10 12751 NIACIN//LAROPIPRANT//GPR109A

Go to start page